Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-κB inhibitor, through downregulation of NFATc1

Hiroshi Takatsuna, Masataka Asagiri, Takeshi Kubota, Kotaro Oka, Toshihiro Osada, Chie Sugiyama, Hiroaki Saito, Kazuhiro Aoki, Keiichi Ohya, Hiroshi Takayanagi, Kazuo Umezawa

Research output: Contribution to journalArticlepeer-review

137 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-κB inhibitor, through downregulation of NFATc1'. Together they form a unique fingerprint.

Medicine & Life Sciences